CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Berlin, Germany and 91 other locations
This is an interventional, open-label, non-randomised, multicentre, single-arm phase II clinical trial.Eligible patients with hepatic oligometastatic...
Phase 2
Berlin, Germany and 10 other locations
Conjugate M9140 in Participants with Advanced Non-Small Cell Lung Cancer (Substudy NSCLC);* PROCEADE PanTumor: A Phase 1b/2, Multicenter, O ...
Phase 1, Phase 2
Berlin, Germany and 80 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Berlin, Germany and 59 other locations
efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/...
Phase 1, Phase 2
Berlin, Germany and 31 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...
Phase 2
Berlin, Germany and 122 other locations
This is an open-label, phase 1/2, multiple-indication platform study to explore safety, potential predictive immune-related biomarkers, and early eff...
Phase 1, Phase 2
Berlin, State of Berlin, Germany and 14 other locations
of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic...
Phase 3
Berlin, Germany and 227 other locations
plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic...
Phase 2, Phase 3
Berlin, Germany and 220 other locations
with nab-p/gem, in participants with untreated metastatic Pancreatic Ductal Adenocarcinoma (PDAC) with homozygous methylthioadenosine phosph...
Phase 2, Phase 3
Berlin, Germany and 268 other locations
Clinical trials
Research sites
Resources
Legal